NOX4 inhibition potentiates immunotherapy by overcoming cancer-associated fibroblast-mediated CD8 T-cell exclusion from tumors
K Ford, CJ Hanley, M Mellone, C Szyndralewiez… - Cancer research, 2020 - AACR
Determining mechanisms of resistance to αPD-1/PD-L1 immune-checkpoint immunotherapy
is key to developing new treatment strategies. Cancer-associated fibroblasts (CAF) have …
is key to developing new treatment strategies. Cancer-associated fibroblasts (CAF) have …
Tetanus toxin fragment C: structure, drug discovery research and production
Tetanus toxoid (TTd) plays an important role in the pharmaceutical world, especially in
vaccines. The toxoid is obtained after formaldehyde treatment of the tetanus toxin. In …
vaccines. The toxoid is obtained after formaldehyde treatment of the tetanus toxin. In …
Repurposing plant virus nanoparticles
KL Hefferon - Vaccines, 2018 - mdpi.com
Plants have been explored for many years as inexpensive and versatile platforms for the
generation of vaccines and other biopharmaceuticals. Plant viruses have also been …
generation of vaccines and other biopharmaceuticals. Plant viruses have also been …
Intrastructural help: harnessing T helper cells induced by licensed vaccines for improvement of HIV Env antibody responses to virus-like particle vaccines
H Elsayed, G Nabi, WJ McKinstry, KK Khoo… - Journal of …, 2018 - Am Soc Microbiol
Induction of persistent antibody responses by vaccination is generally thought to depend on
efficient help by T follicular helper cells. Since the T helper cell response to HIV Env may not …
efficient help by T follicular helper cells. Since the T helper cell response to HIV Env may not …
Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre …
A Allen, C Wang, LJ Caproni, G Sugiyarto… - Cancer Immunology …, 2018 - Springer
Vaccination with DNA that encodes cancer antigens is a simple and convenient way to raise
immunity against cancer and has already shown promise in the clinical setting …
immunity against cancer and has already shown promise in the clinical setting …
Plant-based vaccines and cancer therapy: Where are we now and where are we going?
N Rahimian, HR Miraei, A Amiri, MS Ebrahimi… - Pharmacological …, 2021 - Elsevier
Therapeutic vaccines are an effective approach in cancer therapy for treating the disease at
later stages. The Food and Drug Administration (FDA) recently approved the first therapeutic …
later stages. The Food and Drug Administration (FDA) recently approved the first therapeutic …
[HTML][HTML] Production of recombinant anti-cancer vaccines in plants
JH Lee, K Ko - Biomolecules & Therapeutics, 2017 - ncbi.nlm.nih.gov
Plant expression systems have been developed to produce anti-cancer vaccines. Plants
have several advantages as bioreactors for the production of subunit vaccines: they are …
have several advantages as bioreactors for the production of subunit vaccines: they are …
Chloroplast engineering: Fundamental insights and its application in amelioration of environmental stress
Chloroplasts are specialized organelle that are responsible for converting light energy to
chemical energy, thereby driving the carbon dioxide fixation. Apart from photosynthesis …
chemical energy, thereby driving the carbon dioxide fixation. Apart from photosynthesis …
Plant-made vaccines in the fight against cancer
A Wong-Arce, O González-Ortega… - Trends in …, 2017 - cell.com
Immunotherapies constitute an important trend in developing new cancer treatments, and
several promising candidates are under evaluation in clinical trials. Plants have entered the …
several promising candidates are under evaluation in clinical trials. Plants have entered the …
Expression and immunogenicity assessment of a plant-made immunogen targeting the cytotoxic T-lymphocyte associated antigen-4: a possible approach for cancer …
S Yiemchavee, A Wong-Arce… - Journal of …, 2021 - Elsevier
Cancer immunotherapy is a promising intervention to fight against this global health
problem. In particular targeting immune checkpoints, such as cytotoxic T-lymphocyte …
problem. In particular targeting immune checkpoints, such as cytotoxic T-lymphocyte …